Safety and Immunogenicity of RVM-V001 in Healthy Individuals Previously Vaccinated With BNT162b2 and mRNA-1273
Clinical trial NCT05420077 · TERMINATED
Trial details
- NCT number
- NCT05420077
- Sponsor
- RVAC Medicines (US), Inc.
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-09-12
- Primary completion
- 2023-06-02
- Enrollment
- 13
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.